Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 and Lisinopril in Muscular Dystrophies
NCT01126697Phase 3Completed
- Sponsor
- Cooperative International Neuromuscular Research Group
- Start
- Feb 2010
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of Coenzyme Q10 mucoadhesive tablets, lisinopril in Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), limb-girdle muscular dystrophy (LGMD), sponsored by Cooperative International Neuromuscular Research Group. Started Feb 2010; status: completed.
02
Drugs
Coenzyme Q10 mucoadhesive tabletslisinopril
03
Conditions
Duchenne muscular dystrophy (DMD)Becker muscular dystrophy (BMD)limb-girdle muscular dystrophy (LGMD)
Beyond the preview
Go deeper on NCT01126697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01126697.